Company Overview - SkiStar AB is listed on the Mid Cap list of the Nasdaq Stockholm exchange and operates mountain resorts in Sweden and Norway, including Sälen, Vemdalen, Åre, Hammarbybacken, Hemsedal, and Trysil [6] - The company is divided into three segments: Operation of Mountain Resorts, Property Development & Exploitation, and Operation of Hotels [6] - SkiStar aims to create memorable mountain experiences and develop sustainable destinations while offering high-quality accommodation, activities, products, and services [6] Upcoming Financial Report - SkiStar AB will publish its Interim Report for the period from 1 September 2024 to 31 May 2025 on Thursday, 19 June 2025, at 07:00 a.m. CEST [1] - A conference call with a web presentation will be held on the same day at 10:00 a.m. CEST, featuring CEO Stefan Sjöstrand and CFO Sara J Uggelberg [2][1] - The presentation will be conducted in English, and there will be a Q&A session available via phone and chat [1] Additional Information - A recorded version of the web presentation will be accessible on the same webpage after the live presentation [3] - For further inquiries, contact details for CEO Stefan Sjöstrand and CFO Sara J Uggelberg are provided [5]

Advanced Micro Devices CEO Lisa Su is set to take the stage for a keynote presentation Thursday on the chipmaker's latest developments in artificial intelligence. https://t.co/JcU3D1hTcz ...

Conference Call Scheduled for Today, June 11, 2025 at 4:30pm ET CEA Industries to Provide Business Update and Discuss Strategic Implications of Fat Panda Acquisition Louisville, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), today announced that it has published an updated investor presentation, now available on the Investor Relations section of its website. Management will host a live conference call today, June 11, 2025, at 4:30p ...

Jazz Pharmaceuticals (JAZZ) FY Conference June 11, 2025 10:00 AM ET Speaker0 Good morning, everyone. Thanks so much for joining us. I'm Andrea Newkirk, one of the biotech analysts here at Goldman Sachs, and I'm really pleased to be joined by Phil Johnson, CFO and Rob Yunone, EVP of Global Head of R and D and CMO of Jazz. Thank you guys both for joining us this morning. Speaker1 Thanks for having us. Speaker0 Maybe we'll start at a high level here. There's so much macro uncertainty going on right now. Maybe ...

May 23 was a significant day for patients, oncologists and investors in the treatment of head and neck cancer. In preparation for presentations at the American Society of Clinical Oncology, or ASCO, both Bicara Therapeutics Inc. (NASDAQ:I am a private investor based out of Toronto, Canada and I have been investing since 2003. After 8 years in Corporate Finance with a Canadian Telecom company I have decided to dedicate myself full-time to the capital markets. I write on Seeking Alpha to demonstrate my financ ...

Company to host webcast on Thursday, June 12 at 6:00 pm ETHAMPTON, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that data from the Company’s Phase 2 study of barzolvolimab in chronic spontaneous urticaria will be presented at the EAACI Congress 2025 being held in Glasgow, Scotland. Abstracts will be available on the meeting website Thursday, June 12th at 6:01 pm ET/ Friday, June 13th at 12:01 am CEST. Celldex will host a webcast on Thursday, June 12th at 6:00 pm ET to discus ...

Kura Oncology (KURA) FY Conference June 10, 2025 11:20 AM ET Speaker0 Thanks Speaker1 everyone for joining us. I'm Andrea Newkirk, one of the biotech analysts here at Goldman Sachs and I'm really pleased to be joined by Troy Wilson, President and CEO of Cura Oncology. Thanks so much Troy for joining us. Speaker0 My pleasure. Thank you for the chance to participate. Speaker1 Yeah, of course. Well maybe I will open it up to you for some high level remarks on the company, the overview of your clinical programs ...

Performant Financial (PFMT) Conference June 10, 2025 10:30 AM ET Speaker0 Good day, and welcome to Q2 Investors Summit Virtual. We appreciate your participation in today's virtual event. Up next, we are pleased to introduce Performant Healthcare. If you would like to ask a question during the webcast, you may click the q and a icon button on the right side of your screen. Please type your question into the box and click send to submit it. At this time, it is my pleasure to hand over the session to Rohit Ram ...

Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetesSEATTLE, June 09, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced an upcoming podium presentation highlighting ongoing clinical data from the investigator-sponsored, first-in-human study transplanting UP421, an allogeneic primary islet cel ...

Company Overview - Serina Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing drug candidates for neurological diseases and other indications using its proprietary POZ Platform™ technology [7] - The company is headquartered in Huntsville, Alabama, on the campus of the HudsonAlpha Institute of Biotechnology [7] Industry Context - The biotechnology sector is currently experiencing a bear market, with approximately 25% of the 700 to 800 publicly traded US biotech companies having negative enterprise values [3] - The upcoming webinar event titled "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?" aims to discuss investment opportunities in this challenging environment [2][3] Event Details - Serina's CEO, Steven A. Ledger, will present at the Tribe Public's Webinar on June 11, 2025, at 8:30 am Pacific / 11:30 am Eastern [2] - Participants can submit questions for the CEO before and during the event, which will be hosted by Tribe Public's Managing Member, John F. Heerdink, Jr. [6]